419 related articles for article (PubMed ID: 27669433)
21. A specific RAGE-binding peptide inhibits triple negative breast cancer growth through blocking of Erk1/2/NF-κB pathway.
Dai X; Hou Y; Deng T; Lin G; Cao Y; Yu G; Wei W; Zheng Q; Huang L; Ma S
Eur J Pharmacol; 2023 Sep; 954():175861. PubMed ID: 37380046
[TBL] [Abstract][Full Text] [Related]
22. U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.
Caccuri F; Ronca R; Laimbacher AS; Berenzi A; Steimberg N; Campilongo F; Mazzuca P; Giacomini A; Mazzoleni G; Benetti A; Caselli E; Presta M; Di Luca D; Fraefel C; Caruso A
Oncotarget; 2017 Jul; 8(27):44533-44549. PubMed ID: 28562350
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
Lee GA; Hwang KA; Choi KC
Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
[TBL] [Abstract][Full Text] [Related]
24. Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation.
Evankovich J; Lear T; Mckelvey A; Dunn S; Londino J; Liu Y; Chen BB; Mallampalli RK
FASEB J; 2017 Sep; 31(9):3894-3903. PubMed ID: 28515150
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
26. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
27. RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer.
Pujals M; Mayans C; Bellio C; Méndez O; Greco E; Fasani R; Alemany-Chavarria M; Zamora E; Padilla L; Mitjans F; Nuciforo P; Canals F; Nonell L; Abad M; Saura C; Tabernero J; Villanueva J
Oncogene; 2023 Aug; 42(35):2610-2628. PubMed ID: 37468678
[TBL] [Abstract][Full Text] [Related]
28. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
[TBL] [Abstract][Full Text] [Related]
29. Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.
Sun X; Zhang J; Wang Z; Ji W; Tian R; Zhang F; Niu R
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208810
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
Kong Q; Qiu M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
[TBL] [Abstract][Full Text] [Related]
31. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
[TBL] [Abstract][Full Text] [Related]
32. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
Tafani M; Schito L; Pellegrini L; Villanova L; Marfe G; Anwar T; Rosa R; Indelicato M; Fini M; Pucci B; Russo MA
Carcinogenesis; 2011 Aug; 32(8):1167-75. PubMed ID: 21642357
[TBL] [Abstract][Full Text] [Related]
34. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
35. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
[TBL] [Abstract][Full Text] [Related]
36. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
37. Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.
Snyder KA; Hughes MR; Hedberg B; Brandon J; Hernaez DC; Bergqvist P; Cruz F; Po K; Graves ML; Turvey ME; Nielsen JS; Wilkins JA; McColl SR; Babcook JS; Roskelley CD; McNagny KM
Breast Cancer Res; 2015 Mar; 17(1):46. PubMed ID: 25887862
[TBL] [Abstract][Full Text] [Related]
38. RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer.
Azizan N; Suter MA; Liu Y; Logsdon CD
Biochem Biophys Res Commun; 2017 Nov; 493(1):592-597. PubMed ID: 28867179
[TBL] [Abstract][Full Text] [Related]
39. HMGB1-activated fibroblasts promote breast cancer cells metastasis via RAGE/aerobic glycolysis.
Chen Y; Cai L; Guo X; Li Z; Liao X; Zhang X; Huang L; He J
Neoplasma; 2021 Jan; 68(1):71-78. PubMed ID: 33030958
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
